Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1
Open Access
- 13 September 2010
- journal article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 29 (48), 6343-6356
- https://doi.org/10.1038/onc.2010.366
Abstract
In a previous study it was found that the therapeutic effects of QLT0267, a small molecule inhibitor of integrin-linked kinase (ILK), were influenced by Her2/neu expression. To understand how inhibition or silencing of ILK influences Her2/neu expression, Her2/neu signaling was evaluated in six Her2/neu-positive breast cancer cell lines (LCC6Her2, MCF7Her2, SKBR3, BT474, JIMT-1 and KPL-4). Treatment with QLT0267 engendered suppression (32–87%) of total Her2/neu protein in these cells. Suppression of Her2/neu was also observed following small interfering RNA-mediated silencing of ILK expression. Time course studies suggest that ILK inhibition or silencing caused transient decreases in P-AKTser473, which were not temporally related to Her2/neu downregulation. Attenuation of ILK activity or expression was, however, associated with decreases in YB-1 (Y-box binding protein-1) protein and transcript levels. YB-1 is a known transcriptional regulator of Her2/neu expression, and in this study it is demonstrated that inhibition of ILK activity using QLT0267 decreased YB-1 promoter activity by 50.6%. ILK inhibition was associated with changes in YB-1 localization, as reflected by localization of cytoplasmic YB-1 into stress granules. ILK inhibition also suppressed TWIST (a regulator of YB-1 expression) protein expression. To confirm the role of ILK on YB-1 and TWIST, cells were engineered to overexpress ILK. This was associated with a fourfold increase in the level of YB-1 in the nucleus, and a 2- and 1.5-fold increase in TWIST and Her2/neu protein levels, respectively. Taken together, these data indicate that ILK regulates the expression of Her2/neu through TWIST and YB-1, lending support to the use of ILK inhibitors in the treatment of aggressive Her2/neu-positive tumors.This publication has 102 references indexed in Scilit:
- Role of Microtubules in Stress Granule AssemblyPublished by Elsevier BV ,2009
- Expression of activated signal transducer and activator of transcription-3 predicts poor prognosis in cervical squamous-cell carcinomaBritish Journal of Cancer, 2009
- Polysomes, P bodies and stress granules: states and fates of eukaryotic mRNAsCurrent Opinion in Cell Biology, 2009
- Epithelial-Mesenchymal Transition Markers in Pancreatic Ductal AdenocarcinomaPancreas, 2009
- Twist Is Transcriptionally Induced by Activation of STAT3 and Mediates STAT3 Oncogenic FunctionPublished by Elsevier BV ,2008
- Reprogramming mRNA translation during stressCurrent Opinion in Cell Biology, 2008
- Epidermal Growth Factor Receptor Cooperates with Signal Transducer and Activator of Transcription 3 to Induce Epithelial-Mesenchymal Transition in Cancer Cells via Up-regulation of TWIST Gene ExpressionCancer Research, 2007
- Upregulation of Twist-1 by NF-κB Blocks Cytotoxicity Induced by Chemotherapeutic DrugsMolecular and Cellular Biology, 2007
- Glycogen Synthase Kinase 3 Phosphorylates Hypoxia-Inducible Factor 1α and Mediates Its Destabilization in a VHL-Independent MannerMolecular and Cellular Biology, 2007
- The pleiotropic functions of the Y‐box‐binding protein, YB‐1BioEssays, 2003